Scar Clinical Trial
Official title:
Ablative Fractional CO2 Laser Revision for Burn Related Donor Site Scars: A Pilot Randomized Controlled Trial
Verified date | April 2024 |
Source | Medstar Health Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Scarring from burn wounds remains a chronic and often severe sequela of burn injury. Burn wounds may be left to heal by secondary intention or treated with surgical skin grafting; in both circumstances, significant scars likely result. When surgical skin grafting is employed, skin graft harvest sites ("donor sites") likewise result in clinically significant scars. This study will have interventional and observational components. Patients will receive the standard fractional ablative CO2 treatments to their scars resulting from burn wounds allowed to heal by secondary intention and/or those treated with skin grafts. These will be prospectively observed for the duration of the study as well as adjacent normal skin. In addition, a donor site that meets inclusion criteria that would not have otherwise received LSR will be identified as a treatment site. Patients with have one half of their donor sites randomized to standard of care (SOC) treatment, which consists of wound dressings, compression therapy, physical and occupational therapies and the other half randomized to SOC + ablative fractional CO2 laser therapy (LSR).
Status | Active, not recruiting |
Enrollment | 25 |
Est. completion date | July 1, 2026 |
Est. primary completion date | July 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - = 18 years of age - At least 1 second or third degree burn wound that required treatment with split-thickness skin grafts - Donor site with at least a 4 x 4 inch surface area - Able to return to clinical site for treatments and assessments of burn injuries Exclusion Criteria: - Pregnancy or nursing - Oral retinoid medication use within the past 6 months - Medical history of Ehlers-Danlos syndrome, AIDS - Nutritional deficiencies in the opinion of the investigator that would affect wound healing - Wounds complicated by clinically significant infection within past 30 days |
Country | Name | City | State |
---|---|---|---|
United States | MedStar Washington Hospital Center | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
Medstar Health Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of Patient and Observer Scar Assessment Scale, VSS, and Delfin Instruments | The primary endpoint will be assessment of control and treatment halves at follow-up evaluation completed 2 months ± 2 weeks after the final laser treatment.
The change in scale measure from baseline to date of assessment will be used to compare treatment vs control scar halves. This will be calculated and compared using paired t-test with a p-value of 0.05 as the cutoff for significance. |
2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Completed |
NCT01706848 -
Celotres for Improvement in Wound Healing and Resulting Scar Consequences Following Suturing of a Wound
|
N/A | |
Recruiting |
NCT01177358 -
Botox in the Healing of Surgical Wounds of the Neck
|
Phase 2 | |
Terminated |
NCT01459666 -
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
|
Phase 4 | |
Completed |
NCT00970671 -
Treatment of Surgical Scars Using the Pulsed Dye Laser
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Completed |
NCT05293652 -
Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar
|
N/A | |
Recruiting |
NCT03406143 -
Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration
|
N/A | |
Completed |
NCT05527756 -
Evaluation of the Cosmetic Outcomes of Totally Endoscopic Cardiac Surgery
|
||
Completed |
NCT02886988 -
Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection
|
Phase 2/Phase 3 | |
Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A | |
Recruiting |
NCT05408117 -
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
|
N/A | |
Completed |
NCT04169438 -
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
|
N/A | |
Terminated |
NCT02520557 -
An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate
|
||
Not yet recruiting |
NCT04621994 -
Cesarean Wound Closure: Dermabond Versus Steri Strips
|
N/A | |
Withdrawn |
NCT03395678 -
Acne Scarring in Skin of Color: Laser vs Microneedling
|
N/A | |
Completed |
NCT02744950 -
Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs
|
N/A | |
Not yet recruiting |
NCT01005992 -
Fractional Photothermolysis for the Treatment of Burn Scars
|
Phase 1 | |
Completed |
NCT04870008 -
Aesthetic Outcome of Running Cuticular Suture Distance (2mm vs 5mm)
|
N/A | |
Recruiting |
NCT04506255 -
Silicone Taping for the Improvement of Abdominal Donor Site Scars
|
N/A |